Literature DB >> 7844376

Pharmacologic inhibitors of tumor necrosis factor production exert differential effects in lethal endotoxemia and in infection with live microorganisms in mice.

M G Netea1, W L Blok, B J Kullberg, M Bemelmans, M T Vogels, W A Buurman, J W van der Meer.   

Abstract

Tumor necrosis factor-alpha (TNF-alpha) and interleukin-1 beta (IL-1 beta) are principal mediators of septic shock; inhibition of TNF-alpha production may ameliorate outcome in severe infections. Pentoxifylline, chlorpromazine, and thalidomide inhibit TNF-alpha production. Their effects were tested in lethal endotoxemia in sensitized mice. Only chlorpromazine significantly improved survival. Chlorpromazine and pentoxifylline significantly reduced postendotoxin circulating TNF-alpha, by 89% and 76%, respectively. Chlorpromazine also significantly reduced IL-1 beta and soluble TNF receptor-P75. No drug improved survival in Klebsiella pneumoniae-infected mice despite significantly lower circulating TNF-alpha concentrations in chlorpromazine- or pentoxifylline-treated animals. The three compounds decreased circulating TNF-alpha in Candida albicans-infected mice, but survival was not influenced. In neutropenic mice, chlorpromazine had no influence on candida in organs, but in normal mice, Candida counts in kidneys were higher in chlorpromazine-treated mice. Thus, inhibition of TNF-alpha production was of no benefit in K. pneumoniae infection and worsened outcome in C. albicans infection.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7844376     DOI: 10.1093/infdis/171.2.393

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  12 in total

Review 1.  Natural pathogens of laboratory mice, rats, and rabbits and their effects on research.

Authors:  D G Baker
Journal:  Clin Microbiol Rev       Date:  1998-04       Impact factor: 26.132

2.  Hyperlipoproteinemia enhances susceptibility to acute disseminated Candida albicans infection in low-density-lipoprotein-receptor-deficient mice.

Authors:  M G Netea; P N Demacker; N de Bont; O C Boerman; A F Stalenhoef; J W van der Meer; B J Kullberg
Journal:  Infect Immun       Date:  1997-07       Impact factor: 3.441

3.  The effects of dexamethasone and chlorpromazine on tumour necrosis factor-alpha, interleukin-1 beta, interleukin-1 receptor antagonist and interleukin-10 in human volunteers.

Authors:  M W Bleeker; M G Netea; B J Kullberg; J Van der Ven-Jongekrijg; J W Van der Meer
Journal:  Immunology       Date:  1997-08       Impact factor: 7.397

Review 4.  Thalidomide and derivatives: immunological investigations of tumour necrosis factor-alpha (TNF-alpha) inhibition suggest drugs capable of selective gene regulation.

Authors:  S M McHugh; T L Rowland
Journal:  Clin Exp Immunol       Date:  1997-11       Impact factor: 4.330

5.  Inhibition of tumor necrosis factor alpha alters resistance to Mycobacterium avium complex infection in mice.

Authors:  S Bala; K L Hastings; K Kazempour; S Inglis; W L Dempsey
Journal:  Antimicrob Agents Chemother       Date:  1998-09       Impact factor: 5.191

Review 6.  Trends in immunotherapy of fungal infections.

Authors:  B J Kullberg
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1997-01       Impact factor: 3.267

7.  Lipopolysaccharide-induced cytokine cascade and lethality in LT alpha/TNF alpha-deficient mice.

Authors:  F Amiot; C Fitting; K J Tracey; J M Cavaillon; F Dautry
Journal:  Mol Med       Date:  1997-12       Impact factor: 6.354

8.  Tumor necrosis factor alpha enhances antifungal activities of polymorphonuclear and mononuclear phagocytes against Aspergillus fumigatus.

Authors:  E Roilides; A Dimitriadou-Georgiadou; T Sein; I Kadiltsoglou; T J Walsh
Journal:  Infect Immun       Date:  1998-12       Impact factor: 3.441

9.  Effective immunomodulatory treatment of Escherichia coli experimental sepsis with thalidomide.

Authors:  Evangelos J Giamarellos-Bourboulis; Helen Poulaki; Nikolaos Kostomitsopoulos; Ismene Dontas; Despina Perrea; Panayotis E Karayannacos; Helen Giamarellou
Journal:  Antimicrob Agents Chemother       Date:  2003-08       Impact factor: 5.191

10.  Involvement of tumour necrosis factor-alpha in Clostridium perfringens beta-toxin-induced plasma extravasation in mice.

Authors:  M Nagahama; A Kihara; H Kintoh; M Oda; J Sakurai
Journal:  Br J Pharmacol       Date:  2008-02-11       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.